Literature DB >> 12003685

Mood disorders and chronic obstructive pulmonary disease: current research and future needs.

Greg L Clary1, Scott M Palmer, P Murali Doraiswamy.   

Abstract

The following review examines the interrelationships between chronic obstructive pulmonary disease (COPD), psychiatric illness, and tobacco use. The influence that these three entities have is very unclear, and this article attempts to address the current knowledge of how each contributes to the other and postulates future directions to explore regarding diagnosis, treatment, and predictive values. Other issues discussed include the pharmacologic treatment of patients with COPD and depression, and an overview of the clinical trial data regarding several different classes of antidepressants. Also reviewed is the impact of pulmonary rehabilitation on psychologic status and quality of life issues in the daily functioning of the COPD patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003685     DOI: 10.1007/s11920-002-0032-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  90 in total

1.  Smoking history and nicotine effects on cognitive performance.

Authors:  M Ernst; S J Heishman; L Spurgeon; E D London
Journal:  Neuropsychopharmacology       Date:  2001-09       Impact factor: 7.853

2.  One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease.

Authors:  M E Kunik; U Braun; M A Stanley; K Wristers; V Molinari; D Stoebner; C A Orengo
Journal:  Psychol Med       Date:  2001-05       Impact factor: 7.723

3.  Sertraline with methylphenidate in an ICU patient.

Authors:  S E McGlohn; J M Bostwick
Journal:  Psychosomatics       Date:  1995 Nov-Dec       Impact factor: 2.386

4.  Personality characteristics of patients with chronic obstructive pulmonary emphysema.

Authors:  D V DeCencio; M Leshner; B Leshner
Journal:  Arch Phys Med Rehabil       Date:  1968-08       Impact factor: 3.966

5.  A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease.

Authors:  A M Yohannes; M J Connolly; R C Baldwin
Journal:  Int J Geriatr Psychiatry       Date:  2001-05       Impact factor: 3.485

6.  Effects of psychotherapy in moderately severe COPD: a pilot study.

Authors:  N Eiser; C West; S Evans; A Jeffers; F Quirk
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

Review 7.  Tobacco cessation among patients with depression.

Authors:  L S Covey
Journal:  Prim Care       Date:  1999-09       Impact factor: 2.907

Review 8.  Considerations for the use of antidepressants in patients with cardiovascular disease.

Authors:  S P Roose
Journal:  Am Heart J       Date:  2000-10       Impact factor: 4.749

9.  Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation.

Authors:  N J Withers; S T Rudkin; R J White
Journal:  J Cardiopulm Rehabil       Date:  1999 Nov-Dec       Impact factor: 2.081

10.  Depression, anxiety, and smoking initiation: a prospective study over 3 years.

Authors:  G C Patton; J B Carlin; C Coffey; R Wolfe; M Hibbert; G Bowes
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

View more
  3 in total

Review 1.  Depression in the patient with COPD.

Authors:  Ian Wilson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 2.  Electroconvulsive therapy in the medically ill.

Authors:  Eric J Christopher
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

3.  Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression.

Authors:  Neil Jordan; Todd A Lee; Marcia Valenstein; Kevin B Weiss
Journal:  J Gen Intern Med       Date:  2007-08-09       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.